Hemo.Labs (Umaia)
Intelligent analysis of laboratory blood tests and personalized preventive health recommendations.
About
Hemo.Labs (developer of the consumer app Umaia) is a Kazakhstani preventive health HealthTech startup founded by Alua Musralina (Founder & CEO). According to its corporate LinkedIn profile, the company was founded in 2024; a permanent headquarters in Astana requires separate confirmation. The service analyzes a user’s laboratory blood test results and biomarkers to generate personalized recommendations for physical activity, sleep, and nutrition. The project was a finalist at Astana Hub Battle 2025, completed the Draper University Hero Program accelerator (Silicon Valley) with support from the Go Abroad program, and was showcased at TechCrunch Disrupt 2025. Participation in accelerator and support programs does not constitute an investment transaction, and venture funding remains under verification. A seed round fundraising request has been removed from active statuses pending dated confirmation from the company.
Founders
Team information is compiled from open sources and may be updated by our editors.
RAEM Coverage
Profile history
Sources
- Hemo.Labs: How a Kazakhstani Founder Built AI Blood Analytics, Reached Draper University and TechCrunch Disrupt ↗RAEM.KZ publication
- Top 7 MedTech Startups in Kazakhstan: How Artificial Intelligence and Tech Are Saving Lives ↗RAEM.KZ publication
- LinkedIn (Hemo.Labs) | Draper University | Go Abroad Recorded by editors
- Official website ↗Primary source
Is this your company?
Verify that you represent Hemo.Labs (Umaia) to update this profile and receive inquiries from investors and partners.
Similar startups
All in sector →
AI platform for ultra-early stroke diagnosis from CT scans. US agreement expanding into cardiology and oncology, with an FDA regulatory submission planned for 2027.

AI diagnostics of rare eye diseases using OCT scans. Founded in 2023 by Yana Ten, Arman Ospanov, and Doszhan Zhusupov; focused on the Chinese market per statement on 16.04.2026.

Automated medical examination complexes (ASMO) for 1-minute express employee checkups at industrial sites. Winner of the Altyn Sapa 2023 award.

Digital clinic and telemedicine consultations with on-duty doctors. $150k round at a $2M valuation raised in summer 2025 (interview 11.12.2025).